Skip to content
value.today
BeyondSpring Inc. logo

BeyondSpring Inc.

BYSI
$22 Mmarket cap on Oct 30, 2026-38.5% since Jan 2024
Compare
World rank
#24,101
Revenue
—
For year ending December-2025
Net income
$-1 M
SEC filing
Employees
—

BeyondSpring Inc. in brief

BeyondSpring Inc. is a listed company in the Biotechnology industry, based in Florham Park, New Jersey, USA. It was founded in 2010. Its market value was $22 M on 30 October 2026, which makes it the 24,101st largest listed company in the world and the 4,139th largest in the USA on this site. Min Qiu is its chief executive. Its shares trade under the symbol BYSI (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About BeyondSpring Inc.

BeyondSpring is an Innovative Immuno Oncology Cancer Therapies company with a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using an ubiquitination platform. It is having 91 employees as on 2020. The headquarters is in USA.

BeyondSpring Inc. timeline

3 events, 2010–2017
  1. 2010
  2. 🏁
    · approximate
    Founded
  3. 2016
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2017
  6. 🔔
    Initial public offering on Nasdaq
    Final prospectus filed with the SEC on 9 March 2017; shares registered for exchange trading on 6 March 2017.

Events of BeyondSpring Inc. from the company record and SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$129 M$258 M$387 M$516 M2020202120222023202420252026

World rank over time

▼ down 11,913 places since 2020
2020-01-01: #12221#12,22120202021-01-01: #11359#11,35920212022-01-07: #19471#19,47120222022-12-25: #24937#24,93720222023-07-30: #26182#26,18220232024-01-05: #26537#26,53720242026-03-08: #10758#10,75820262026-08-01: #20428#20,42820262026-10-09: #23655#23,65520262026-10-30: #24134#24,1342026

Rank in USA: #2,655 (Jan 2020) · #2,784 (Jan 2021) · #3,951 (Jan 2022) · #4,747 (Dec 2022) · #4,850 (Jul 2023) · #4,206 (Jan 2024) · #2,104 (Mar 2026) · #3,828 (Aug 2026) · #4,060 (Oct 2026) · #4,142 (Oct 2026)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
-92.1%
Net margin
—
Operating margin
—
Return on equity
—
Liabilities / assets
192.5%
Net debt
$-42M
Revenue growth
0.0%
R&D / revenue
1894.8%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue —, net income $-55M—FY18Fiscal year ending Dec 2019: revenue —, net income $-38M—FY19Fiscal year ending Dec 2020: revenue —, net income $-61M—FY20Fiscal year ending Dec 2021: revenue $1M, net income $-64M$1MFY21Fiscal year ending Dec 2022: revenue $1M, net income $-33M$1MFY22Fiscal year ending Dec 2023: revenue —, net income $-21M—FY23Fiscal year ending Dec 2024: revenue —, net income $-11M—FY24Fiscal year ending Dec 2025: revenue —, net income $-1M—FY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025——$-9M$-1M—
Dec 2024——$-9M$-11M—
Dec 2023——$-15M$-21M—
Dec 2022$1M0.0%$-37M$-33M-2465.2%
Dec 2021$1M—$-66M$-64M-4754.1%
Dec 2020——$-64M$-61M—
Dec 2019——$-40M$-38M—
Dec 2018——$-58M$-55M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-20M$0M$-20M——
Dec 2024$-16M$0M$-17M——
Dec 2023$-16M$0M$-17M——
Dec 2022$-27M$0M$-27M——
Dec 2021$-47M$3M$-50M$-1.64—
Dec 2020$-44M$0M$-44M$-2.03—
Dec 2019$-48M$0M$-48M$-1.55—
Dec 2018$-40M$0M$-40M$-2.42—

Quarterly results

USD · three months to · source: SEC filings
RevenueNet income
Three months to Sep 2024: revenue —, net income $-2M—Sep ’24Three months to Dec 2024 (from the annual report): revenue —, net income $-2M—Dec ’24Three months to Mar 2025: revenue —, net income $4M—Mar ’25Three months to Jun 2025: revenue —, net income $-2M—Jun ’25Three months to Sep 2025: revenue —, net income $-2M—Sep ’25Three months to Dec 2025 (from the annual report): revenue —, net income $-2M—Dec ’25Three months to Mar 2026: revenue —, net income $-2M—Mar ’26Three months to Jun 2026: revenue —, net income $-1M—Jun ’26

Latest quarter to Jun 2026: revenue —, net income $-1M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.

SEC filings

Official filings of BeyondSpring Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
—
Operating income
$-9 M
Net income
$-1 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$26 M
Total liabilities
$50 M
Total equity
$-32 M

As of December-2025

Top 19 institutional investors in BeyondSpring Inc.#

As of Sep 30, 2026
19 institutions held 5.4 M shares (about 13.1% of the shares outstanding) on Sep 30, 2026. The ten largest hold 13.1%. Source: SEC Form 13F filings, filed through Nov 16, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 19 largest institutional investors in BeyondSpring Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Decheng Capital LLC3,065,702-735,000 (-19.34%)7.46%$2 MNov 13, 2026
2Vanguard Capital Management LLC695,207+68,750 (+10.97%)1.69%$1 MNov 13, 2026
3BlackRock, Inc.668,863-4,052 (-0.60%)1.63%$1 MNov 13, 2026
4Geode Capital Management, LLC367,7400 (0.00%)0.89%$0 MNov 6, 2026
5State Street Corp259,320+28,200 (+12.20%)0.63%$0 MNov 12, 2026
6Vanguard Fiduciary Trust Co181,1960 (0.00%)0.44%$0 MNov 13, 2026
7Northern Trust Corp62,0240 (0.00%)0.15%$0 MNov 16, 2026
8UBS Group AG53,702-9,330 (-14.80%)0.13%$0 MNov 10, 2026
9Citadel Advisors LLC13,605New0.03%$0 MNov 16, 2026
10Meridian Wealth Management, LLC10,000-5,000 (-33.33%)0.02%$0 MNov 5, 2026
11Vanguard Global Advisers, LLC4,8020 (0.00%)0.01%$0 MNov 13, 2026
12Morgan Stanley4,5700 (0.00%)0.01%$0 MNov 13, 2026
13National Bank Of Canada /fi/2,8750 (0.00%)0.01%$0 MNov 16, 2026
14Trifecta Capital Advisors, LLC1,5000 (0.00%)0.00%$0 MOct 21, 2026
15Simplex Trading, LLC929-236 (-20.26%)0.00%$0 MNov 4, 2026
16Jpmorgan Chase & Co495+176 (+55.17%)0.00%$0 MNov 12, 2026
17Jones Financial Companies Lllp98New0.00%$0 MNov 13, 2026
18SBI Securities Co., Ltd.760 (0.00%)0.00%$0 MOct 22, 2026
19Caitong International Asset Management Co., Ltd10 (0.00%)0.00%$0 MOct 29, 2026

Mutual funds holding BeyondSpring Inc.#

8 funds hold shares worth $2 M (about 2.5% of the company). Since their previous reports 5 added shares and 3 sold, buying $0 M net.
Mutual funds holding BeyondSpring Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.343,113$1 M0.83%<0.01%−0.4%Jun 30, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.282,669$0 M0.69%<0.01%+7.3%Jun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC164,922$0 M0.40%<0.01%+2.9%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors105,492$0 M0.26%0.01%+35%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC66,108$0 M0.16%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC42,932$0 M0.10%<0.01%+3.1%May 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC23,601$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC7,272$0 M0.02%<0.01%+20%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jun 30, 2026. The 8 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at BeyondSpring Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
0
0 purchases, 0 insiders
Sold, 12 months
0
0 sales, 0 insiders
Net, 12 months
0
open market only
Insiders on file
6
since
-$1.1 M$0Jun 2025: bought $0 (0 trades), sold $1.1 M (5 trades)Jun 25Jul 2025: bought $0 (0 trades), sold $92 K (11 trades)JulAug 2025: bought $0 (0 trades), sold $143 K (13 trades)AugSep 2025: bought $0 (0 trades), sold $125 K (21 trades)SepOct 2025: bought $0 (0 trades), sold $553 K (13 trades)Oct
Bought (open market)Sold (open market)Hover a month for the totals
BeyondSpring Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Lan HuangChief Executive Officer, Director, 10% ownerGiftindirect-260,582——local0Form 4
filed Decheng Capital China Life Sciences USD Fund II, L.P.10% ownerSellindirect-45,5131.76080 Klocal1.52 MForm 4
filed Decheng Capital China Life Sciences USD Fund II, L.P.10% ownerSellindirect-85,7981.720148 Klocal1.56 MForm 4
filed Decheng Capital Global Healthcare GP, LLC10% ownerSellindirect-17,9601.65030 Klocal1.65 MForm 4
filed Decheng Capital Global Healthcare GP, LLC10% ownerSellindirect-28,4951.65047 Klocal1.67 MForm 4
filed Decheng Capital Global Healthcare GP, LLC10% ownerSellindirect-107,3611.700183 Klocal1.70 MForm 4
filed Decheng Capital Global Healthcare GP, LLC10% ownerSellindirect-2,3901.7704 Klocal1.80 MForm 4
filed Decheng Capital Global Healthcare GP, LLC10% ownerSellindirect-3,9791.8107 Klocal1.81 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals. This company files with the SEC as a foreign issuer; its insiders often report prices in the home currency, so amounts are as filed and not converted to dollars

Markets and events: BeyondSpring Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
2.3 M
5.5% of shares · 41.86 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2026-08-13 16:21 UTC, code LUDP, resumed 16:26 UTC

Fails to deliver

  • : 9,763 shares at $0.52
  • : 536 shares at $0.52
  • : 10,722 shares at $0.46
  • : 10,358 shares at $0.43
  • : 11,948 shares at $0.45

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

BeyondSpring Inc. scorecard#

Passes 2 of the 9 checks that could be worked out. Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation0 of 4
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✗Price to book below its peers' medianNo price to bookShareholders' equity is negative.
    • –Price to sales below its peers' medianNo Price to sales on file.
    • ✗Free cash flow yield above 5%-92.1%Free cash flow is -92.1% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth1 of 1
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
    • ✓Net income higher than five years earlier-$1 M-$1 M in fiscal 2025 against -$61 M in 2020.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 2
    • ✗Profitable in the newest year-$1 MNet income -$1 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • –Operating margin above its peers' medianNo operating margin on file.
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health1 of 2
    • ✓Short-term assets cover short-term liabilities1.5×Current ratio 1.54 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

BeyondSpring Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

BeyondSpring Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue0001.41.40.20000
Research and development4.42.67.326374231528910
Selling, general and administrative4.66.17.81331239.05.99.11.9
General and administrative——————9.05.99.11.9
Operating income−8.9−8.8−15−37−66−64−40−58−98−12
Interest and finance income0.10.10.30.20.10.10.20.20.10.0
Interest expense and finance costs———0.00.10.10.2———
Other non-operating income (expense)———1.11.40.000.30.9—
Income before tax−8.6−8.8−14−36−65−64−40−57−96−13
Income tax0.10.1r−0.10.23.600———
Income from discontinued operations−5.5−7.8−7.9———————
Net income including minority interests−14−17−22−36−68−64−40−57−96−13
Minority interests' share of net income———−3.0−4.0−2.8−2.2−2.6−4.6−0.5
Net income attributable to shareholders−1.0−11−21−33−64−61−38−55−92−12
Earnings per share, basic-0.02-0.28-0.54-0.85-1.64-2.03-1.55-2.42-4.40-0.75
Earnings per share, diluted————-1.64-2.03-1.55-2.42-4.40-0.75
Shares, weighted average (basic)———393930————
Shares, weighted average (diluted)————393025232116
Balance sheet
Cash and cash equivalents7.82.95.43442110363.92712
Short-term investments4.80—2.9310——3.1—
Other current assets0.10.10.20.81.00.40.40.30.30.4
Current assets2129183975113415.93215
Property, plant and equipment0.20.20.31.91.40.20.20.30.10.1
Right-of-use (leased) assets0.30.50.75.52.02.22.5———
Non-current assets5.15.76.47.76.53.63.71.20.50.2
Total assets2634254682117457.13315
Accounts payable0.40.30.61.11.72.22.59.63.40.4
Debt due within a year———01.60————
Current liabilities14118.07.4151410164.82.6
Long-term debt————02.21.4———
Lease liabilities (non-current)00.30.64.01.51.41.9———
Non-current liabilities3638404240113.4———
Total liabilities50494849552513164.82.6
Retained earnings−408−407−396−375−342−278−217−179−124−32
Shareholders' equity−32−33−27−6.0278830−7.82712
Minority interests8.219−8.5−8.1−5.8−1.70.9−1.61.00.1
Total equity−24−14−35−14218731−9.42812
Total liabilities and equity2634254682117457.13315
Shares outstanding41403939393928232317
Cash-flow statement
Share-based compensation0.72.30.81.73.28.22.16.623—
Cash from operating activities−20−16−16−27−47−44−48−40−29−14
Capital expenditure−0.1−0.2−0.1−0.0−2.8−0.1−0.0−0.2−0.1−0.1
Cash from investing activities11−12−0.118−20−0.1−0.02.9−3.2−0.1
Debt issued0.33.90———————
Shares issued2.03.000011369145115
Cash from financing activities5.0270.03.40.011880134815
Exchange-rate effect on cash——————0.00.30.0−0.1
Change in cash−3.9−1.7−17−7.2−687432−24160.9
Report10-K10-K10-K20-F20-F20-F20-F20-F20-F20-F

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Events at BeyondSpring Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Delisting noticeFiling
  • Delisting noticeFiling
  • Auditor changedFiling

Delisting notice 2 · Auditor changed 1 · Acquisition or sale completed 2 · Directors and officers 2 · Material agreement 4 · Shareholder vote 2 · Results announced 7

BeyondSpring Inc.: events reported to the SEC
FiledWhat happenedFiling
Shareholder vote8-K
Acquisition or sale completed8-K
Delisting notice8-K
Material agreement8-K
Delisting notice8-K
Results announced8-K
Directors and officers8-K/A
Directors and officers8-K
Results announced8-K
Results announced8-K
Material agreement8-K
Results announced8-K
Material agreement8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Auditor changed8-K
Results announced8-K
Acquisition or sale completed8-K
Material agreement8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Oct 13, 2026

Lobbying by BeyondSpring Inc.#

$20 K spent on lobbying the US Congress and federal agencies in 2024, most often on health issues.

Lobbying, 2024
$20 K
#1,324 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2024
2026 so far
—
  • Health Issues2 reports

Lobbying firms hired in 2024

Farragut Partners LLP $20 K

BeyondSpring Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2024$20 K—2
2023$80 K—4
2022$80 K—4
2021$80 K—4

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “BeyondSpring Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

How BeyondSpring Inc. compares in Biotechnology

  • Market cap$22 M · higher than 18% of 726
  • Revenue growth0.0% · higher than 42% of 438
  • FCF yield-92.1% · higher than 11% of 449

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
BeyondSpring Inc.🇺🇸$22 M——0.0%
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at BeyondSpring Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show BeyondSpring Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about BeyondSpring Inc.? Suggest a correction